Alphavirus vectors based on Sindbis virus and Semliki Forest virus (SFV) were characterized as potential gene transfer vectors. Initial studies were performed using vectors engineered to transfer either lacZ or green fluorescent protein (GFP). High levels of gene transfer were achieved in human primary fibroblasts, BHK and 293T cells, with low levels of transduction observed in more than 20 other target cells. Alphavirus-based expression was generally very high, but transient in every cell type. Replication-competent alphavirus was never detected in SFV preparations but could be produced by Sindbis-based vectors at a frequency
Introduction
Semliki Forest virus, Sindbis virus, and several pathogenic encephalitis-producing viruses (eg Venezuelan equine encephalitis virus, VEE) are all members of the alphavirus genus. 1 The typical alphavirus consists of an enveloped nucleocapsid containing a single-stranded, positive-polarity RNA genome of approximately 12 000 nucleotides that is capped at the 5Ј end and polyadenylated at the 3Ј terminus. The alphaviral genome functions directly as an mRNA encoding its own replicase. In the case of Sindbis virus, virion entry occurs by receptormediated endocytosis after attachment with the aid of cell surface heparan sulfate. 2 Translation of the 5Ј portion of the genome results in production of a polyprotein complex, which is cleaved into the four nonstructural proteins (nsP1-4). This is followed by the replication of the plus-strand genome into full-length minus strands, which efficiently produce both new genomic RNAs and subgenomic RNA in an autocatalytic manner. Alphavirus gene expression is transient by nature owing to non-nuclear replication and because wild-type virus infection results in cell lysis. Replication using alphavirus-based systems is extremely efficient with approximately 10 5 new virions per cell being produced using the host's own trans- of up to 3 × 10 −3 infectious units per ml. We constructed a human clotting factor IX (hFIX) cDNA-containing Sindbis virus and compared it with hFIX cDNA-harboring adenoviral and retroviral vectors. In most cases, hFIX levels obtained with Sindbis vector were initially at least an order of magnitude higher than those obtained with other viral vectors. These data demonstrate that alphavirus vectors compare favorably with adenovirus vectors as systems to promote high-level transient gene expression and should be considered as an alternative vector for gene transfer and potential gene therapy studies. Gene Therapy (2000) 7, 472-480.
lational machinery. The efficiency of alphavirus replication has been exploited for the development of RNAbased systems for the production of recombinant proteins in eukaryotic cells. [3] [4] [5] [6] [7] [8] Alphaviruses may also be useful vectors for gene therapy, as they have been reported to have a broad host range, replicate efficiently in the cytoplasm of host cells, have an inserted gene size capacity of at least 5 kb, and produce high levels of recombinant proteins. Despite a vast amount of data about the biology of these viruses and several reports on the expression of single genes in specific cell types, relatively little is known about their general utility as bona fide vectors for gene therapy purposes. Lundstrom 12 tested the SFVSIVgp160 virus preparation on different primary macaque cells in vitro and also in vivo via intramuscular and intravenous injection. Sindbis virus with lacZ reporter gene has been tested on various cell lines and cultured rat neurons and in vivo in mouse brain. 13, 14 Meruelo's group demonstrated on human tumor cells, again using lacZ reporter gene, that Sindbis virions can be re-targeted by altering the structure of the viral envelope. 15, 16 There are also reports from several groups that alphaviral vectors have potential as delivery vehicles for DNA-based vaccines. 12, [17] [18] [19] [20] Although the reports mentioned above increase our understanding about the utility of alphaviral vectors as gene transfer agents, some crucial information is lacking. For example, to our knowledge, there are no published reports about direct comparison of Sindbis and SFV vectors on different cell types and only one paper compares an alphaviral vector with an adenoviral vector. 10 In this article, we present data about characteristics of both SFV and Sindbis virus as gene transfer vectors and evaluate their utility in comparison to each other and to other vector types on different target cells.
Results

Alphaviral vector production
The two recombinant alphaviral vector systems are based on similar designs where each replicon contains plus and minus strand promoters, the genes for the replicase enzyme complex (nsP1-4), and a multiple cloning site for transgene insertion (Figure 1 ). The replicon contains the packaging signal and is packaged into virions when helper functions are provided in trans. The defective helper constructs contain deletions of the replicase complex genes, followed by the genes encoding viral structural proteins. When these two RNA molecules are introduced into host cells in concert, both RNAs are replicated and virions are produced. Theoretically, only the vector RNA with the transgene is packaged into the virion particles, which are capable of transducing target cells, but are replication-incompetent. For more information about alphaviral vector systems, see Frolov et al. 21 Both Sindbis and SFV vector stocks were produced in infectious particles per ml. The main factors influencing vector production were the quality and amount of in vitro transcribed RNA and the efficiency of electroporation (data not shown). Vector collection at 48 h after electroporation usually yielded 10-100 times lower titers and were discarded for routine work. For Sindbis virus vector production, two different defective helper plasmids, DH-BB and DH(26S), were tested. These helper systems originate from distinct Sindbis strains that display different host cell specificities. Both of the helpers are engineered to be defective for the packaging signal, but if co-packaging of vector and helper RNAs were to occur, the formation of replicationcompetent viruses (RC␣V) would require only a single recombination event. SinTGL viruses (a Sindbis vector expression an HSV thymidine kinase-green fluorescent protein fusion gene, see Materials and methods), produced with the DH(26S) helper, were used to transduce BHK cells to characterize the kinetics of viral vector transduction. The number of GFP-positive cells was determined to be 19% at 4 h after transduction and 86% at 24 h after transduction. When these cells were followed beyond the 24-h time point, the amount of green cells decreased drastically, accompanied by global cell death in the culture. These data suggested the potential outgrowth of replication-competent virus. To measure RC␣V, we tested Sindbis preparations with plaque assay and determined that frequency of RC␣V formation was 3-5 × 10 −5 for the DH-BB helper virus and 3 × 10 −3 -2 × 10 −4 for the DH(26S) helper virus. Using a highly sensitive serial passage assay, we detected RC␣V at 1 × 10 −3 in DH-BB helper preparations. All the SFV stocks were produced with Helper2 RNA that provides conditionally infectious SFV particles. 4 In this system, the spike protein of SFV is mutated to be unable to support virus entry. When these Helper2 SFV virions are collected, they must be treated with chymotrypsin to remove a protective peptide in order for viral entry functions to be activated. If a recombination to RC␣V were to occur with Helper2, it could not be amplified unless continually exposed to chymotrypsin. Since the frequency of replication-competent SFV formation is known to be very high (2 × 10 −2 -2.5 × 10
) with the native Helper1, it is crucial to use Helper2 in SFV production. 4 All SFV stocks produced were analyzed by plaque assay and were determined to be free of RC␣V (at the level of Ͻ1 × 10 −6 by both direct plaque assay and sensitive serial passage assays).
Alphaviral host range
Several reports suggest that alphaviruses have broad host range and efficient replication in many different cell types (see Introduction for references). To verify these purported claims, we set up a series of transduction experiments using SFV-lacZ and Sindbis-lacZ (DH(26S) helper) where the same amount of viral vector (MOI = 1) was used to transduce various cells. The cells were stained with X-gal 24 h after transduction and the number of blue cells was compared with the number obtained with BHK cells, the standard target for alphaviruses. The results of this experiment are displayed in Table 1 . It was observed that both SFV and Sindbis were able to transduce all the cells tested to some extent. However, many cell lines (transduction score + or ++ in Table 1 ) had significantly fewer transduced cells in comparison to BHK cells, and some of them in fact were practically resistant to these viruses (transduction score +/−). We did not observe any species-specific differences between the rodent and primate cells analyzed.
To analyze further the ability of SFV and Sindbis to transduce various cell lines GFP vectors were used followed by FACS analysis. SinTGL (DH-BB helper) and SFVTGL virus stocks were used to transduce several cell lines (MOI = 0.3). The percentage of GFP-positive cells and the mean level of GFP expression in the positive population were followed by FACS analysis up to 4 days after transduction. These results (data not shown) were in accordance with the preliminary screening experiments, indicating that BHK, 293T and human primary fibroblasts are the best targets for both Sindbis and SFV. In most of the cell lines, SFV yielded as good or better transduction efficiency than Sindbis virus. This also held true with the amount of GFP expression in the positive cells, SFVbased expression being consistently higher than Sindbisbased (eg in BHK cells the mean fluorescence signal amount was 464 for SinTGL versus 791 for SFVTGL).
The number of positive cells after transduction was followed over time and the results are shown in Figure 2 . The overall trend was that the number of GFP-positive cells was highest at 1 day after transduction and declined to an undetectable level in most of the cases between days 2 and 4 after transduction. Exceptions of this were 293T cells and human primary fibroblasts transduced with SFVTGL. These cells retained a significant popu- lation of positive cells 4 days later. When different cell lines and viruses were compared in terms of the GFPpositive population, almost all cell lines displayed the same kinetics: a rapid drop from the 1 day maximum followed by steady decline toward the undetectable level at day 4.
Optimization of the alphaviral transduction conditions
Transduction with alphaviruses is a very fast and simple procedure, yielding good results with a 1-h incubation of virus in serum free media at 37°C. It is known that retroviral vector transduction can be enhanced by the addition of polycations (for example polybrene) to the media. In addition, lowering the transduction temperature to 32°C, centrifugation during transduction or transduction on fibronectin-coated plates has been shown to be effective methods to improve retrovirus-mediated gene transfer. 22, 23 Since Sindbis and SFV are also enveloped RNA Gene Therapy viruses, we decided to test these conditions on alphaviruses, using SFV3-lacZ virus (MOI = 0.3) on BHK cells. Transductions were performed (1) using standard procedure; (2) by centrifugation (1000 g, 1 h at 32°C); (3) on human fibronectin-coated plates; and (4) by using various concentrations of polybrene in media. Figure 3 shows the results of this experiment, indicating that the conditions that enhance retroviral vector transduction do not significantly improve alphaviral transduction. Only the use of fibronectin plates improved the efficiency slightly, but the difference was not statistically significant.
Comparison of alphaviral, adenoviral and retroviral vectors
To evaluate the performance of alphaviral vectors in comparison to adenoviral and retroviral vectors, we used SinF9 produced with helper DH(26S) (MOI = 1), AdF9 (MOI = 15) and RVF9 (MOI = 5) produced with amphotropic envelope in PA317 packaging cells, in parallel to transduce various cell lines. 24 All vectors produced the human Factor IX (FIX) gene product, which is easy to quantify. The accumulation of FIX in the growth media was followed over time until 4 days after transduction. As shown in Figure 4 , the Sindbis-based FIX expression begins very high, more than 1000 ng/ml in many cell lines, and declines rapidly to a very low level. The exceptions to this pattern are A549 and HepG2 cells that were shown in previous experiments (Table 1) to be difficult to transduce by Sindbis virus.
The adenovirus-based FIX expression increased for the first 2 days after transduction and then stabilized at a relatively high level, more than 1000 ng/ml, in most of the cell lines. Both primary human fibroblasts and BHK cells appeared to be poorer targets for adenoviral vectors. The retrovirus-based FIX expression was generally low or intermediate and remained steady during the period of detection.
Taken together, these experiments show that high level production of clinically relevant protein is possible when alphaviral vectors are used. This production is, however, extremely transient and declines in 4 days to lower levels than those obtained by adenovirus-or retrovirus-based expression without exceptions.
Discussion
Numerous studies during the last several years have provided useful information about alphaviruses (SFV and Sindbis) as protein expression vectors (see Introduction).
These reports repeatedly claim that alphaviruses have a broad host range and yield highly efficient but transient gene expression in several target cells. However, from the data presented in these reports, it is difficult to judge what broad host range actually means or, what are the tropism differences between SFV and Sindbis virus, and how do alphaviral vectors behave compared to other common viral vectors. The purpose of this study was to clarify these issues and investigate various aspects related to use of these vectors in gene therapy studies.
Two reports have indicated a very high frequency of replication-competent virus formation with alphaviral vectors predicting that it is technically difficult to produce helper virus-free stocks of recombinant SFV and Sindbis viruses. 4, 25 In the recombinant SFV production system, altering the structure of the viral spike protein has circumvented this problem. 4 The virions produced are inactive and become infectious only upon chymotrypsin digestion to remove the modification from the spike protein. This safety mechanism does not per se prevent recombination between the helper and vector constructs, but renders the resulting replication-competent particles incapable of infecting and amplifying in culture cells. Indeed, in our hands, this worked as expected and no replication-competent SFV was observed in any of our experiments.
The current Sindbis virus vector production system is a two-component system resembling that of SFV, but it lacks the spike protein safety mechanisms and leaves the system vulnerable for RC␣V outbreaks. In the plaque assay on BHK cells, we detected RC␣V at a frequency of 3-5 × 10 −5 for the DH-BB helper virus and 3 × 10 −3 -2 × 10 −4 for the DH(26S) helper virus. It is obvious that this high production of replication-competent virus will seriously diminish the utility of the current Sindbis virus production system for any in vivo gene transfer studies and may obscure some of the results obtained with this vector. Therefore, it is necessary to develop more disabled Sindbis packaging systems that would make formation of RC␣V more difficult. In fact, Frolov and coworkers 26 have recently shown that this is possible by splitting the helper system into two parts and replacing the Sindbis capsid protein by respective protein from the related alphavirus, Ross River virus. During the preparation of this manuscript Polo et al 27 reported on an alphavirus packaging cell line that can also be used to generate helper-free vector preparations.
It has been shown that transduction with retroviral vectors can be improved by various means to enhance the interaction between the virus and its receptor. 22, 23 These methods include transduction in the presence of polycations low-speed/low-temperature centrifugation and incubation in fibronectin-coated plates. Although retroviruses and alphaviruses use different mechanisms to enter their target cells, they are both large enveloped viruses with positive strand RNA genomes. Despite the structural similarities, it was obvious that alphaviruses do not benefit from the modifications that enhance retroviral transduction (Figure 3) . On the contrary, it appeared that both centrifugation and the presence of polybrene significantly impair the transduction efficiency, the latter effect increasing with greater concentration of polybrene. A similar observation was made earlier with Sindbis virus using various polyanions and cations, suggesting that alphaviral attachment is different from retroviral attachment and can actually be disturbed by the presence of polyionic compounds. 28 The use of fibronectin-coated plates yielded a small improvement, but it was statistically insignificant.
To collect more data about the host range of SFV and Sindbis viruses, we used SFV-lacZ and Sin-lacZ on several available cell lines to quickly screen their host ranges (Table 1) . This experiment revealed a wide variety of transduction efficiencies, the best being BHK cells, 293 cells or cell lines derived from them (293T and PHOENIX ampho), mouse myoblast line (C2C12) and human primary fibroblasts. This preliminary screen also showed that some cell lines are practically resistant to alphaviral transduction under the conditions yielding almost 100% efficiency on BHK cells. These observations were confirmed in more quantitative experiments, where transduction efficiency was determined by using a fluorescent reporter gene and results were obtained by FACS analysis (Figure 2 ). Based on these data, the following conclusions can be made. BHK cells are the best target cells for both SFV and Sin vectors, followed by 293T cells and primary human fibroblasts. SFV was generally better than Sindbis in terms of transduction efficiency and the
Figure 4 Temporal pattern of human factor IX expression in various cell lines after transduction with adenovirus, retrovirus and Sindbis virus vectors. The cells were transduced with indicated human FIX-carrying viral vectors (Sindbis: MOI = 1; adenovirus: MOI = 5; retrovirus: MOI = 15) and the FIX concentration in the growth medium was determined by ELISA daily until day 4 after transduction. All data points were analyzed in triplicate, with mean values shown.
Gene Therapy level of reporter gene expression. However, high transduction efficiency was not necessarily accompanied by a high transgene expression. The kinetics of transgene expression were rapid (peaking within 24 h) and were essentially identical, regardless of the virus or cell type used. Only 293T cells and primary fibroblasts were slightly different, displaying a significant population of positive cells 4 days after transduction. It is unclear on which level the block of alphaviral transduction exists in the resistant cell types. Our data suggest that the block is in the viral attachment and/or internalization, since some cell lines show only low transduction efficiency, but the expression of the reporter gene in the positive cells is high. This indicates that the alphaviral replication is fully supported in the cells that contain alphaviral replicons. It is possible that the alphavirus-resistant cell types are not expressing the correct combination of cell surface molecules required for the attachment and entry of these viruses. The determinants (receptors) of alphaviral entry and their significance have not yet been fully established. A cell surface glycosaminoglycan heparan sulfate (HS) has been shown to be one attachment determinant for Sindbis virus and viral infectivity can be influenced by the cells' cholesterol content. 2, 29, 30 The presence of a high number of these molecules could partly explain why some cells are good targets for Sindbis virus. On the other hand, it was shown that the requirements for HS as a receptor were highly variable among different Sindbis strains and the attachment of another alphavirus, Ross River virus, was independent of this molecule.
Some primary cells are excellent targets for alphaviruses. In our experiments, the primary human fibroblasts were highly transducible by SFV and Sindbis. Also, the mouse myoblast cell line C2C12, that has some features of primary myoblasts, was also a very good target for Sindbis virus (Table 1) . This trend is supported by findings of Mossman and coworkers 12 who showed that primary macaque kidney fibroblasts and lung epithelial cells were transduced with SFV-SIVgp160 equally well as the BHK cells. In contrast, they found that peripheral blood mononuclear cells were completely resistant to this virus in vitro, which is in accordance with findings by Ohno et al 15 who showed that the leukemia cell line HL-60 and lymphoma cell line Daudi are resistant to Sindbis virus made with DH-BB helper. It is also tempting to speculate, based on the fact that BHK and 293 cells were the best targets for SFV and Sindbis virus, that cells of renal origin would be good targets for alphaviral gene transfer. However, this is opposed by the results of Corsini et al 13 who found that a newborn human kidney cell line NB324K had only 0.4% relative transduction efficiency compared with BHK cells.
To study the features of alphaviral (Sindbis virus) vector compared with adenoviral and retroviral vectors, several cell lines were transduced with these vectors carrying human clotting factor IX cDNA (Figure 4) . The concentration of hFIX in the medium was then followed for 4 days after transduction. Sindbis-based expression climbed rapidly to a very high level 24 h after transduction and then quickly dropped to levels that were barely detectable with the ELISA method used. This was as expected based on the transient expression properties of Sindbis replication. The remaining hFIX in the media 4 days after transduction was not likely due to newly synthesized protein, but rather leftover from earlier time points. (FIX has a relatively long half-life in cell culture medium.) Sindbis virus did not perform well in the cell lines A549 and HepG2, previously shown to be poor targets for Sindbis virus (Table 1 ). In these cell lines the expression started at relatively low levels, possibly due to low transduction efficiency, and declined according to normal alphaviral kinetics. Retrovirus-based expression initiated later than with the other virus types, since the integration and subsequent stable expression requires at least one cell division. Expression based on this vector type remained very stable over time in most of the cell lines. Adenovirus-based expression typically took 2 days to reach the maximum level and then stayed fairly constant during the next 48 h. Fibroblasts and BHK cells appeared to be relatively resistant to adenoviral vectors, allowing only marginal levels of expression.
Roks and coworkers 10 studied cardiovascular cells as targets for SFV and adenoviral vectors. They found that these vector types worked equally well for vascular smooth muscle cells and cardiomyocytes, but adenoviruses were strikingly better for endothelial cells. Kinetics of early infection with adenovirus and SFV on aortic smooth muscle cells were very similar to our results with adenovirus reaching maximal expression at 48 h after transduction and SFV about 5 h after transduction. Interestingly, the population of positive cells remained stable with both vectors at least 72 h after transduction suggesting similarities to dermal fibroblasts in our experiments.
Our results suggest that alphavirus vectors can be a useful addition to the list of potential gene therapy vectors. They may be particularly valuable in situations that require high-level transient gene expression within a few hours after transduction, such as certain cancer gene therapies or vaccination. The next level of analysis of these vectors will necessitate detailed studies in appropriate animal models.
Materials and methods
Cell lines
The cell lines used in the preliminary screening for alphaviral transduction efficiency are indicated in Table  1 
Design and cloning of the viral vectors
The molecular cloning and preparation of factor IX retroviral vector (GCNCF9) and factor IX adenoviral vector (AVC3FIX5) are described by Chen et al 31 and Lozier et al, 32 respectively. The human factor IX cDNA expression cassette in these vectors was driven by a CMV promoter. The Semliki Forest virus vector system including plasmids pSFV1, pSFV3-lacZ and pSFV-Helper2 was purchased from Life Technologies (Gaithersburg, MD, USA). Sindbis expression system, including plasmids pSinRep5, SinRep/lacZ, DH-BB helper and DH(26S) helper was from Invitrogen (Carlsbad, CA, USA). Vector pSINF9 was created by cloning the human factor IX cDNA from plasmid pCMVFIX into pSinRep5. 31 To generate the GFP reporter vector, the herpes simplex virus thymidine kinase (HSVtk) green fluorescent protein (GFP) fusion construct pETLGB was modified as follows: GFP from the plasmid pGreenLantern (Life Technologies) was cut out with NotI and blunt-ended. 33 pETLGB was cut with NheI, blunt-ended and cut with EcoRI to excise a fragment con-taining tk and the linker sequence. These two fragments were ligated into SmaI-cut, blunt-ended and EcoRI-cut pUC19 to yield pTGL8. The blunt-ended XbaI fragment from the plasmid pTGL8 was cloned into the SmaI site of pSFV1 to create SFV-TGL and into the StuI site of pSinRep5 to create Sin-TGL.
Production and characterization of the alphaviral vectors Sindbis and SFV plasmid constructs were linearized and used as templates for in vitro transcription reactions using SP6 mESSAGE mACHINE kit (Ambion, Austin, TX, USA). Synthetic alphaviral RNA was purified according to the manufacturer's instructions and 10-30 g, along with the same molar amount of helper RNA, was used to electroporate BHK cells as described earlier to produce alphaviral particles. 34 SFV viral stocks were produced with Helper2 RNA and Sindbis stocks with DH-BB or DH(26S) helper RNA. SFV and Sindbis supernatants were collected 24 and 48 h after electroporation and analyzed for titers and replication-competent viruses.
The lacZ-containing viruses were titered directly by counting blue cells 24 h after transduction and X-gal staining while the TGL-containing viruses titers were titered by determining fluorescent cells in the population 24 h after transduction using FACS analysis (FACScalibur, Becton Dickinson, San Jose, CA, USA). Factor IX-containing viruses were titered indirectly using a dot blot method described by Nelson et al. 35 Replication-competent alphaviruses in the preparations were determined by plaque assay on BHK cells: a dilution series of viruses was made in OptiMEM (Life Technologies) and used to transduce cells as described below. Infected cells were overlaid with 1 × MEM (10% FBS), 1% agarose, incubated at 37°C and observed for plaque formation 5 days later. The viral preparations were also checked by passaging them serially three times on BHK cells.
Transduction with alphaviral vectors
All the cell lines were transduced with SFV or Sindbis as follows: cells were split on plates 6-24 h before transduction. After a single wash with PBS (containing Ca 2+ and Mg 2+ ), the virus was added to the cells in a standard volume of OptiMEM: 150 l for a 24-well plate, 500 l for a 12-well plate and 1 ml for a six-well plate. Transduction was carried out for 1 h at 37°C, followed by removal of the virus-containing media and addition of fresh media. Semliki Forest viruses produced with the Helper2-packaging system were activated before use with ␣-chymotrypsin (Sigma) according to the SFV expression kit manual (Life Technologies).
Viral transduction efficiency was determined by staining for ␤-galactosidase activity with X-gal (lacZ vectors) or by FACS analysis for green fluorescence, using a FITC filter and counting at least 10 000 events per sample (TGL vectors). The number of positive cells in the population was calculated to yield transduction efficiency. Production of human factor IX was assayed by analyzing the supernatants with ELISA (Asserachrom IX:Ag kit, Diagnostica Stago, Asnières, France).
To optimize the alphaviral transduction procedure, three different variations of SFV3-lacZ transduction were tested: (1) transduction with 1, 4 or 8 g/l polybrene (hexadimethrine bromide, Aldrich, Milwaukee, WI, USA) in viral media; (2) spin-transduction for 1 h at 32°C, 1000 g (2500 r.p.m.) using a Sorvall RT 6000 D centrifuge (DuPont); and (3) transduction on fibronectin-coated plates (BioCoat human fibronectin cellware, Becton Dickinson). Normalized transduction efficiency was determined by assaying cellular ␤-galactosidase activity using a colorimetric CPRG method and total protein using the Bradford method as described in Caplen et al. 36 
